Search

Search Results

• 

  Relaxin-2 for heart failure with preserved ejection fraction: a comment on the termination of a phase-II trial investigating the relaxin-2 analogue, LY3540378

  Thomas Bernd Dschietzig, Guy Salama

  2024-12-30

  https://doi.org/10.4081/cardio.2024.56

  3707

  PDF: 876

  HTML: 68

• Lipoprotein(a): what clinicians need to know

  Laibah Arshad Khan, Muhammad Hanif, Ahmed Mustafa Rashid

  2025-09-01

  https://doi.org/10.4081/cardio.2025.80

  151

  PDF: 278

  HTML: 18
• 

  Global Cardiology issue highlights

  Andrew J.S. Coats

  2024-06-28

  https://doi.org/10.4081/cardio.2024.41

  3435

  PDF: 388

  HTML: 0

• The Global Implementation Guidelines Initiative: how to optimize cardio-renal-metabolic care worldwide

  Fausto J. Pinto, Stefan D. Anker, William T. Abraham, John J. Atherton, Javed Butler, Vijay Chopra, Andrew J.S. Coats, Yann Colardelle, Maria Rosa Costanzo, Veronica Dean, Gerasimos Filippatos, Martha Gulati, Julio Rosenstock, John Teerlink, Subodh Verma, Jose Luis Zamorano, Yuhui Zhang, Shelley Zieroth

  2025-04-16

  https://doi.org/10.4081/cardio.2025.68

  3236

  PDF: 466

  Appendix: 361

  HTML: 20
• 

  Welcome to Global Cardiology

  Andrew J.S. Coats

  2023-12-20

  https://doi.org/10.4081/cardio.2023.1

  2292

  pdf: 133

  HTML: 4
• 

  Evolving targets for heart failure: the journey so far

  Giuseppe M.C. Rosano, Jerneja Farkas

  2023-11-28

  https://doi.org/10.4081/cardio.2023.6

  1922

  pdf: 275

  HTML: 4
• 

  To clip or not to clip moderate-to-severe functional mitral regurgitation in patients with heart failure?

  Muhammad Shahzeb Khan, Javed Butler, Tim Friede, Piotr Ponikowski, Stefan D. Anker

  2024-11-05

  https://doi.org/10.4081/cardio.2024.44

  2963

  PDF: 745

  HTML: 10

• Large language models to write scientific manuscripts: to be considered but not trusted

  Christian Basile, Stefan D. Anker, Gianluigi Savarese

  2025-06-30

  https://doi.org/10.4081/cardio.2025.74

  710

  PDF: 170

  HTML: 0

• Importance of patient-reported outcomes in cardiovascular illnesses

  Wardah Rasool, Ahmed Kamal Siddiqi, Laibah Arshad Khan

  2025-06-30

  https://doi.org/10.4081/cardio.2025.69

  1910

  PDF: 379

  HTML: 79
• 

  Treatment pathways in patients with heart failure with preserved ejection fraction and obesity: perspectives from cardiology specialists and patients

  Javed Butler, Sanjiv J. Shah, Melissa Magwire, Carlos Campos, Muhammad Shariq Usman, Anthony Hoovler, Anup Sabharwal, Barry A. Borlaug

  2024-06-28

  https://doi.org/10.4081/cardio.2024.38

  1833

  PDF: 486

  SUPPLEMENTARY MATERIAL: 291

  GRAPHICAL ABSTRACT: 258

  HTML: 4
• 

  Clinical trial design, endpoints and regulatory considerations in heart failure

  Giuseppe M.C. Rosano

  2024-03-28

  https://doi.org/10.4081/cardio.2024.18

  5571

  PDF: 415

  HTML: 69
• 

  Advanced cancer as a heart failure like syndrome due to cardiac wasting cardiomyopathy: facts and numbers

  Muhammad Shahzeb Khan, Javed Butler, Laibah Arshad Khan, Markus S. Anker

  2024-12-30

  https://doi.org/10.4081/cardio.2024.58

  2920

  PDF: 482

  HTML: 9
• 

  Defining iron replete status in patients with heart failure treated with intravenous iron

  Khawaja M. Talha, Javed Butler, Stephan von Haehling, Mitja Lainscak, Piotr Ponikowski, Stefan D. Anker

  2023-12-21

  https://doi.org/10.4081/cardio.2023.17

  2859

  pdf: 275

  HTML: 47
• 

  Biological plausibility and implications of obesity associated valvular heart diseases

  Francesco Fioretti, Brian R. Lindman, Javed Butler

  2024-11-05

  https://doi.org/10.4081/cardio.2024.49

  2422

  PDF: 636

  HTML: 1